Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax^® compared with Turbuhaler^® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain

Josep Darbà1 Department of Economics, Universitat de BarcelonaCorrespondence[email protected]

Gabriela Ramírez2 BCN Health Economics & Outcomes Research S.L., Barcelona

Juan L García-Rivero3 Hospital Laredo, Cantabria

Sagrario Mayoralas4 Hospital Ramón y Cajal, Madrid

José Francisco Pascual5 Hospital General Universitario de Alicante, Alicante

Diego Vargas6 Hospital de Alta Resolución el Toyo, Andalusia

Adi Bijedic7 Market Access and HEOR Department, TEVA Pharmaceutical, Madrid, Spain

show all

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tanja Fens, Guiling Zhou, Maarten J. Postma, Eugène P. van Puijenbroek & Job F.M. van Boven. (2021) Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?. Expert Opinion on Pharmacotherapy 22:7, pages 923-935.
Read now

Marc Miravitlles, Alicia Marín, Alicia Huerta, David Carcedo, Alba Villacampa & Jaume Puig-Junoy. (2020) Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1643-1654.
Read now

Articles from other publishers (3)

Suhaj Abdulsalim, Mazhuvancherry Kesavan Unnikrishnan, Mohan K. Manu, Saud Alsahali, Alian A. Alrasheedy, Antony P. Martin, Brian Godman & Abubakr A. Alfadl. (2019) Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India. PharmacoEconomics - Open 4:2, pages 331-342.
Crossref

Suhaj Abdulsalim, Mazhuvancherry Kesavan Unnikrishnan, Mohan K. Manu, Alian A. Alrasheedy, Brian Godman & Donald E. Morisky. (2018) Structured pharmacist-led intervention programme to improve medication adherence in COPD patients: A randomized controlled study. Research in Social and Administrative Pharmacy 14:10, pages 909-914.
Crossref

. (2017) DuoResp Spiromax cost saving for COPD in Spain. PharmacoEconomics & Outcomes News 772:1, pages 16-16.
Crossref

Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax^® compared with Turbuhaler^® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain

Citations (5)

Read on this site (2)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax^® compared with Turbuhaler^® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain